FHL2 and cancer: Whilst the FHL2-GLI2 and DYNLL1-GLI2 rearrangements were present in 17/26 (65%) and 1/26 (4%) of SSTs, respectively, none of the other ovarian sex cord-stromal tumors tested by RT-PCR, namely adult-type granulosa cell tumors (n = 28), fibromas, fibrothecomas and thecomas (n = 14) and Sertoli-Leydig cell tumors (SLCTs, n = 6), and none of the 9950 tumors of 33 cancer types from TCGA28 harbored the FHL2-GLI2 or DYNLL1-GLI2 fusion genes (Fig. 1h, i, Supplementary Fig. 4, Supplementary Table 4).